Are All Nitrile Gloves Suitable for Chemotherapy Handling?

No. "Nitrile" describes the polymer, not the barrier performance, and chemotherapy handling has its own permeation test — ASTM D6978 — that evaluates glove resistance to a defined set of chemotherapy drugs. A nitrile examination glove can pass every requirement for routine clinical use and still not be evaluated for chemotherapy drugs at all.

The distinction matters because chemotherapy permeation is not the same problem as chemical splash. The drugs are handled at low volumes over long exposure periods, and the failure mode is permeation through the film rather than a visible breach.

Here is what D6978 evaluates, how it differs from generic chemical permeation testing, and the three things to check before a clinic buys.

What does ASTM D6978 measure?

ASTM D6978 is the standard practice for assessing the resistance of medical gloves to permeation by chemotherapy drugs. Gloves are exposed to a defined panel of chemotherapy agents and the time to permeation is measured. A glove earns a claim for a drug when it resists permeation beyond the standard's threshold for the duration specified in the practice.

That produces a per-drug result rather than a single "chemo safe" label. A glove may show a longer breakthrough time against one agent and a shorter one against another, which is why institutional drug lists and glove selection are connected documents rather than separate purchasing decisions.

How does D6978 differ from other permeation tests?

Both tests are permeation tests, and neither substitutes for the other. A clinic handling hazardous drugs is looking for the D6978 result; a clinic choosing gloves for a solvent or cleaning chemical is looking at F739 data for that chemical.

How long is a chemotherapy glove good for once donned?

Follow the manufacturer's stated use time and the institutional protocol, and treat the donning moment as the start of the clock rather than the start of the task. Permeation is a function of contact time, so a glove worn past its stated window is being relied on beyond what was tested — even if it looks intact.

• Change gloves at the interval the manufacturer or protocol states, and immediately after any visible contamination.
• Double gloving is a common institutional practice where the drug list and protocol require it; it does not extend the outer glove's tested window indefinitely.
• Remove and change gloves between handling a drug and touching anything else, so contamination is not carried out of the preparation area.
• Store gloves away from heat, UV and ozone, because aged film loses performance before it shows damage.

What should a clinic check before buying chemo-grade gloves?

Three things, all available on request:

• The D6978 result, per drug — not a generic statement that the glove is "chemotherapy tested".
• The drug list it was tested against, compared with the agents your clinic actually handles.
• The stated use time, so the protocol's change interval sits inside the tested window rather than beyond it.

For routine work, our Protégé 4.0 mil powder-free chemo-grade nitrile gloves carry a chemotherapy glove claim, while standard 4 mil blue nitrile examination gloves cover examination use. Keeping the two visually distinct in the storeroom is the simplest way to stop an exam glove being used where a chemotherapy glove is specified.

Why does the visual distinction matter?

Because the substitution is easy and invisible. Two nitrile boxes on the same shelf, one evaluated against a chemotherapy drug panel and one not, look almost identical at arm's length. Clinics that handle hazardous drugs usually solve it by stocking the chemotherapy glove in a different colour or a differently labelled shelf position, and by naming the product on the preparation-area checklist rather than the word "nitrile".

Where a hazardous drug program is in place, the glove specification should come from the program document — the drug list, the handling procedure and the glove claim reviewed together — and be rechecked when the drug list changes. Our clinic collection groups the glove lines so the specification review starts from a known list.

Ordering for a clinic, lab or care home? Wholesale and multi-site ordering covers case pricing and account setup, and the B2B wholesale collection lists the lines stocked for institutional buyers.

Related reading

• Clinic consumables collection
• Case review: a clinic rechecked its chemo gloves
• Nitrile glove chemical breakthrough: trichloroethylene
• clinic consumables

Buying for a facility rather than a single practice? Request a B2B quote and we will price your volume with Canadian warehouse delivery.

Frequently Asked Questions

Can I use any nitrile glove for chemotherapy handling?

No. Nitrile describes the polymer, not the permeation performance. Chemotherapy handling calls for a glove evaluated against a chemotherapy drug panel, and a glove used for routine examination has usually not been assessed that way at all.

What is ASTM D6978?

It is the standard practice for assessing the resistance of medical gloves to permeation by chemotherapy drugs. Gloves are exposed to a defined panel of agents and the time to permeation is measured, which produces a per-drug result rather than one overall pass or fail.

How often should chemotherapy gloves be changed?

At the interval the manufacturer or your handling protocol states, and immediately after visible contamination. Permeation is driven by contact time, so a glove used past its tested window is being relied on beyond the conditions that were evaluated.

What should I ask for when buying chemo-grade gloves?

Ask for the ASTM D6978 permeation results per drug, the list of drugs the glove was tested against, and the stated use time. Compare the tested drug list with the agents your clinic actually handles before standardising on a glove.

CliniEco Medical is a licensed medical device establishment (MDEL #35334).